Jill Becker retiring at 11 Alive in August after 23 years ajc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajc.com Daily Mail and Mail on Sunday newspapers.
1. Median progression-free survival in the HSCT group was significantly longer than in the non-HSCT group. 2. HSCT was associated with a slightly increased risk of serious adverse events, including graft-versus-host disease (59% vs. 44%, respectively). Evidence Rating Level: 2 (Good) Study Rundown: Advanced cutaneous T-cell lymphoma (CTCL) is a rare and aggressive form of
/PRNewswire/ Vyriad, Inc., announces an expansion of a Phase 1 investigator-initiated trial at Mayo Clinic evaluating the safety and efficacy of Voyager-V1.
Mr T goes incognito during a stealthy shopping trip in LA dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.